SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-20-104402
Filing Date
2020-09-11
Accepted
2020-09-11 16:05:07
Documents
3
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2030265d2_10ka.htm 10-K/A 23648
2 EXHIBIT 31.1 tm2030265d2_ex31-1.htm EX-31.1 9670
3 EXHIBIT 31.2 tm2030265d2_ex31-2.htm EX-31.2 9750
  Complete submission text file 0001104659-20-104402.txt   44108
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 10-K/A | Act: 34 | File No.: 001-38709 | Film No.: 201170959
SIC: 2834 Pharmaceutical Preparations